Physician
Urology
Dr. Surena F. Matin, MD
|
|
Give Review
Surena Matin practices Urology. He attended Weill Cornell Medical College of Cornell University. Weill Cornell Medical College of Cornell University is ranked 18 in research and 49 in primary care medicine He received 1 awards: "Fellow (FACS)". Surena F. Matin is a published MD as well. He has 101 publications published. The latest was: The Role Of Metastasectomy In Patients With Renal Cell Carcinoma With Sarcomatoid Dedifferentiation: A Matched Controlled Analysis. Dr. Surena F. Matin accepts Medicare.
Publications
- Contemporary Evaluation and Management of Upper Tract Urothelial Cancer.
- Positive Margins after Radical Nephrectomy with Venous Thrombectomy: Controversies and Treatment Options.
- Surgical considerations for patients with metastatic Renal cell carcinoma.
- Gene-environment interaction of genome-wide association study-identified susceptibility loci and meat-cooking mutagens in the etiology of Renal cell carcinoma.
- Comparison of Single-Docking Robotic-Assisted and Traditional Laparoscopy for Retroperitoneal Lymph Node Dissection during Nephroureterectomy with Bladder Cuff Excisio...
- Neoadjuvant Systemic Therapy Before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity: Contemporary Results Using the Clavien Sys...
- Surgical Management for Local Retroperitoneal Recurrence Of Renal Cell Carcinoma After Radical Nephrectomy.
- Cryoablation for Small Renal Masses: Selection Criteria, Complications, and Functional and Oncologic Results.
- Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward.
- Role of partial nephrectomy as cytoreduction in the management of metastatic Renal cell carcinoma.
- Posttraumatic stress and depressive symptoms in Renal cell carcinoma: association with quality of life and utility of single-item distress screening.
- Clinically nonmetastatic Renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent.
- Lynch Syndrome: A Primer for Urologists and Panel Recommendations.
- Re: A Randomized Trial of Robot-assisted Laparoscopic Radical Cystectomy.
- Implementation of a Very Low Calorie Diet in Patients Undergoing Urologic Surgery: Room for Improvement?
- Mitochondrial DNA Copy Number in Peripheral Blood Leukocytes and the Risk of Clear Cell Renal Cell Carcinoma.
- 'Discontent is the first necessity of progress', Thomas A. Edison.
- Preoperative Predictors of Pathologic Lymph Node Metastasis in Patients with Renal Cell Carcinoma Undergoing RPLND.
- Clear cell papillary Renal cell carcinoma in patients with von Hippel-Lindau syndrome-clinicopathological features and comparative genomic analysis of 3 cases.
- Technical challenges in 3 T magnetic resonance spectroscopic imaging of the Prostate-A single-institution experience.
- Safety and Diagnostic Accuracy of Percutaneous Biopsy in Upper Tract Urothelial Carcinoma.
- Early experience of robotic-assisted inguinal lymphadenectomy: review of surgical outcomes relative to alternative approaches.
- Telemedicine and telesurgery in Cancer care: Inaugural conference at MD Anderson Cancer Center.
- Impact of warm versus cold ischemia on Renal function following partial nephrectomy.
- Isolated Renal Mucormycosis in a Transplantation Recipient.
- Salvage Surgery After Energy Ablation For Renal Masses.
- Neoadjuvant chemotherapy improves survival of patients with upper Tract urothelial carcinoma.
- Randomized controlled trial of expressive writing for patients with Renal cell carcinoma.
- Robotic partial nephrectomy shortens warm ischemia time, reducing suturing time kinetics even for an experienced laparoscopic surgeon: a comparative analysis.
- Partial nephrectomy in the setting of metastatic Renal cell carcinoma.
- Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper Tract urothelial carcinoma.
- Malignant epithelioid angiomyolipoma: tumor and metabolic response to everolimus as evaluated with positron emission tomography.
- Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma.
- Re: pilot trial of sunitinib therapy in patients with von hippel-lindau Disease.
- Real-Time Magnetic Resonance Imaging-Guided Cryoablation of Small Renal Tumors at 1.5 T.
- Radiofrequency ablation of Renal tumours with clinical, radiographical and pathological results.
- Illness Uncertainty and Quality of Life of Patients with Small Renal Tumors Undergoing Watchful Waiting: A 2-year Prospective Study.
- Risk of Cancer-specific mortality following recurrence after radical nephroureterectomy.
- Role of transrectal ultrasonography (TRUS) in focal therapy of prostate Cancer: report from a Consensus Panel.
- Re: Functional Recovery after Partial Nephrectomy: Effects of Volume Loss and Ischemic Injury: M. N. Simmons, S. P. Hillyer, B. H. Lee, A. F. Fergany, J. Kaouk and S. ...
- A Phase 2 Trial of Sunitinib in Patients with Advanced Non-clear Cell Renal Cell Carcinoma.
- Is transureteroureterostomy performed during multi-organ resection for non-urothelial malignancy safe and effective?
- Comprehensive Assessment of Quality of Life and Psychosocial Adjustment in Patients With Renal Tumors Undergoing Open, Laparoscopic and Nephron Sparing Surgery.
- Role of inflammatory related gene expression in clear cell Renal cell carcinoma development and clinical outcomes.
- Can a Durable Disease-Free Survival be Achieved With Surgical Resection in Patients With Pathological Node Positive Renal Cell Carcinoma?
- Laparoscopic adRenalectomy for metachronous metastases after ipsilateral nephrectomy for Renal-cell carcinoma.
- Early Primary Tumor Size Reduction Is an Independent Predictor of Improved Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib.
- Chyluria after radiofrequency ablation of Renal tumors.
- Ablation of Kidney tumors.
- The role of FISH and cytology in upper urinary tract surveillance after radical cystectomy for Bladder cancer.
- Perioperative Outcomes of Laparoscopic Radical Nephroureterectomy and Regional Lymphadenectomy in Patients With Upper Urinary Tract Urothelial Carcinoma After Neoadjuv...
- Metastasectomy after targeted therapy in patients with advanced Renal cell carcinoma.
- Thyroid-like follicular carcinoma of the Kidney with metastases to the lungs and retroperitoneal lymph nodes.
- Chronic kidney disease before and after partial nephrectomy.
- Age and body mass index are independent risk factors for the development of postoperative paralytic ileus after radical cystectomy.
- Radio frequency ablation of Renal tumors in patients with metastatic Renal cell carcinoma.
- Percutaneous biopsy of primary tumor in metastatic Renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessment.
- Upper Tract urothelial carcinoma: Impact of time to surgery.
- High-frequency endoluminal ultrasonography as an aid to the staging of upper Tract urothelial carcinoma: imaging findings and pathologic correlation.
- Can we better select patients with metastatic Renal cell carcinoma for cytoreductive nephrectomy?
- Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper Tract transitional cell carcinoma.
- Determining failure after Renal ablative therapy for Renal cell carcinoma: false-negative and false-positive imaging findings.
- Laparoscopy-assisted radical nephrectomy with inferior vena caval thrombectomy for level II to III tumor thrombus: a single-institution experience and review of the li...
- Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of Renal tumors.
- Impact of ischemia on Renal function after laparoscopic partial nephrectomy: a multicenter study.
- Port-site hernias occurring after the use of bladeless radially expanding trocars.
- Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteria.
- Predictors of unilateral Renal function after open and laparoscopic partial nephrectomy.
- Immunological response to renal cryoablation in an in vivo orthotopic renal cell carcinoma mUrine model.
- Cardiac history and risk of post-cystectomy cardiac complications.
- Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic Renal cell carcinoma.
- Office cystoscopy and transrectal ultrasound-guided Prostate biopsies pose minimal risk: prospective evaluation of 921 procedures.
- Papillary Renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease.
- Outcomes of laparoscopic partial nephrectomy after fellowship training.
- Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
- Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk Renal cell carcinoma.
- Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau Disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Linda...
- Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent Renal cell carcinoma.
- A pilot trial of vascular targeted photodynamic therapy for Renal tissue.
- Current status of debulking nephrectomy in the era of tyrosine kinase inhibitors.
- Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary Renal cell carcinoma.
- Nephron-sparing probe ablative therapy: long-term outcomes.
- Fellowship in endourology, the job search, and setting up a successful practice: an insider's view.
- Comparing lymphadenectomy during radical nephroureterectomy: open versus laparoscopic.
- Contemporary strategies for treating nonhereditary synchronous bilateral Renal tumors and the impact of minimally invasive, nephron-sparing techniques.
- Location of extraRenal tumor extension does not impact survival of patients with pT3a Renal cell carcinoma.
- Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: diagnosis, staging, and surveillance of prostate Cancer.
- Unexpected atypical findings on CT after radiofrequency ablation for small Renal-cell carcinoma and the role of percutaneous biopsy.
- Ability of clinical grade to predict final pathologic stage in upper Urinary tract transitional cell carcinoma: implications for therapy.
- Redefining pT3 Renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system.
- Is radiofrequency ablation safe for solitary Kidneys?
- Laparoscopic radical nephroureterectomy for transitional cell carcinoma: where are we in 2007?
- Cytoreductive nephrectomy in the elderly patient: the M. D. Anderson Cancer Center experience.
- Laparoscopic partial nephrectomy: experience in 60 cases.
- Residual and recurrent disease following Renal energy ablative therapy: a multi-institutional study.
- Conventional and hand-assisted laparoscopic radical nephrectomy: Comparative analysis of 271 cases.
- Laparoscopic cytoreductive nephrectomy: the M. D. Anderson Cancer Center experience.
- The Role Of Metastasectomy In Patients With Renal Cell Carcinoma With Sarcomatoid Dedifferentiation: A Matched Controlled Analysis.
- Upper Tract urothelial carcinoma: epidemiology, high risk populations, and detection.
- Adjuvant sunitinib or sorafenib for high-risk, non-metastatic Renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.
Schools
J amp S Weill M C Cornell Univ
Cleveland Clinic
Procedures Preformed
- AdRenalectomy
- Complete Nephrectomy With Robotic Assistance
- Cystectomy
- Cystometry
- View All
Conditions Treated
- Atrophic Vaginitis
- Bladder Cancer
- Bladder Infection
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
Cleveland Clinic Foundation -
Weill Cornell Medical College of Cornell University
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1215971916 | |
| NPPES Provider LastName | MATIN | |
| NPPES Provider FirstName | SURENA | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Urology | |
| Total Claim Count | 138.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 20.0 | |
| Percent Opioid Claims | 14.49 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1215971916 |
| Last Name Of The Provider | MATIN |
| First Name Of The Provider | SURENA |
| View All |
Similar Doctors
|
Dr. Alvaro I. Montealegre, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Swanson, MD |
|
|
Dr. Peter A. Caputo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Colin P. Dinney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander W. Pastuszak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Kazumi Kamoi |